OLIPHANT LAURA 4

What Happened

• Laura Oliphant, a director of Aehr Test Systems (AEHR), was granted/acquired 1,658 restricted stock units (RSUs) on July 1, 2026. The reported acquisition price is $0.00 (typical for RSU grants); the award includes unvested shares and will convert to common stock only as the RSUs vest.

Key Details

• Transaction date and price: 2026-07-01, Award/Acquisition (A), 1,658 shares, $0.00 per share.
• Shares owned after transaction: Not specified in the provided filing excerpt.
• Vesting: Per footnote, 1/4 of the award vests at the end of each three full calendar months following the grant (i.e., 25% quarterly over ~12 months), conditioned on continued board service.
• Filing timeliness: Report filed 2026-07-02 for a 2026-07-01 transaction (appears timely).
• Footnote summary: F1 = quarterly vesting schedule tied to continued service; F2 = reported amount includes unvested RSUs.

Context

• RSUs are a form of equity compensation that do not represent immediately tradable shares until they vest. Grants are common for directors and executives as compensation and do not, by themselves, indicate buying or selling interest in the open market. Investors tracking insider activity may note director compensation and potential future share dilution as these RSUs vest.